C

Cocrystal Pharma
D

COCP

1.46000
USD
0.00
(0.00%)
Market Closed
Volume
16
EPS
-2
Div Yield
-
P/E
-1
Market Cap
14,853,733
OverviewSignalsIdeasNews
Related Instruments
A
ABEO
-0.15500
(-2.35%)
6.43000 USD
A
AEMD
-0.01600
(-3.95%)
0.38900 USD
A
ALT
-0.05500
(-0.95%)
5.71000 USD
A
AMRX
-0.03000
(-0.42%)
7.15000 USD
A
APVO
-0.03210
(-10.63%)
0.26990 USD
A
AXSM
0.810
(0.78%)
104.990 USD
B
BNGO
0.00000
(0.00%)
3.70000 USD
C
CAPR
-0.615
(-5.66%)
10.245 USD
C
CLSD
-0.00420
(-0.49%)
0.85230 USD
C
COLL
0.015
(0.05%)
28.810 USD
C
CPRX
0.380
(1.58%)
24.480 USD
C
CRVS
0.02000
(0.57%)
3.50000 USD
C
CTRM
0.05000
(2.35%)
2.18000 USD
C
CTXR
-0.02000
(-2.78%)
0.70000 USD
C
CYCC
-0.01000
(-0.69%)
1.44000 USD
D
DARE
-0.01000
(-0.34%)
2.89000 USD
D
DMAC
0.00700
(0.17%)
4.04000 USD
D
DRRX
-0.03100
(-5.47%)
0.53590 USD
E
EBS
-0.11000
(-1.69%)
6.39000 USD
E
ECOR
-0.07000
(-1.41%)
4.91000 USD
E
ENLV
-0.04790
(-4.74%)
0.96210 USD
E
EQ
0.00000
(0.00%)
0.40000 USD
EQT
EQT
-0.060
(-0.11%)
55.610 USD
E
EVOK
-0.03000
(-0.81%)
3.67000 USD
E
EYEN
-0.25000
(-12.50%)
1.75000 USD
F
FATE
-0.02000
(-1.68%)
1.17000 USD
F
FNKO
-0.02000
(-0.51%)
3.91000 USD
G
GALT
-0.02000
(-1.54%)
1.28000 USD
I
IFRX
0.03000
(1.65%)
1.85000 USD
I
IMMP
-0.04000
(-2.00%)
1.96000 USD
I
INO
-0.06000
(-2.98%)
1.95500 USD
I
IONS
-0.295
(-0.89%)
32.970 USD
I
IRWD
-0.05200
(-8.53%)
0.55740 USD
J
JAGX
-0.07000
(-1.55%)
4.45000 USD
K
KALA
-0.10000
(-2.53%)
3.86000 USD
L
LADR
0.080
(0.78%)
10.305 USD
L
LCTX
0.09480
(15.67%)
0.69990 USD
L
LGND
0.430
(0.42%)
101.730 USD
L
LPTX
-0.00620
(-1.67%)
0.36430 USD
L
LTRX
-0.06500
(-2.93%)
2.15000 USD
L
LXRX
-0.00820
(-1.24%)
0.65140 USD
M
MARA
-0.985
(-6.27%)
14.735 USD
M
MDGL
-5.51
(-2.02%)
267.27 USD
M
MRUS
13.405
(32.12%)
55.140 USD
M
MTNB
-0.00320
(-0.38%)
0.83670 USD
N
NERV
0.01000
(0.67%)
1.50000 USD
N
NEXA
-0.29000
(-5.46%)
5.02000 USD
N
NINE
-0.01800
(-3.38%)
0.51520 USD
N
NKTR
0.00400
(0.62%)
0.64810 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
O
OGEN
-0.00070
(-0.36%)
0.19120 USD
O
OMER
-0.06000
(-1.87%)
3.15000 USD
O
ONCY
0.01860
(4.65%)
0.41860 USD
O
OVID
0.00290
(1.01%)
0.29000 USD
P
PAVM
-0.00610
(-0.94%)
0.64200 USD
P
PDSB
0.01000
(0.64%)
1.58000 USD
P
PENN
0.425
(2.90%)
15.090 USD
P
PLX
-0.05000
(-3.01%)
1.61000 USD
R
RCKT
-0.28500
(-4.35%)
6.26500 USD
R
RCMT
0.290
(1.28%)
22.910 USD
R
RIGL
-0.800
(-4.05%)
18.960 USD
R
RMTI
-0.03290
(-3.30%)
0.96500 USD
S
SAGE
-0.08000
(-1.21%)
6.52000 USD
S
SCYX
-0.02550
(-3.25%)
0.75950 USD
S
SIGA
0.07500
(1.29%)
5.90500 USD
S
STOK
-0.14000
(-1.48%)
9.35000 USD
T
TGTX
0.290
(0.85%)
34.530 USD
T
TNXP
2.480
(9.38%)
28.910 USD
T
TXMD
0.01000
(0.70%)
1.44000 USD
U
UBX
0.02100
(2.77%)
0.78000 USD
V
VCEL
-0.440
(-1.06%)
40.970 USD
V
VCYT
-0.245
(-0.89%)
27.145 USD
V
VIR
-0.11500
(-2.49%)
4.50500 USD
V
VKTX
-0.715
(-2.58%)
26.985 USD
V
VTGN
-0.03000
(-1.23%)
2.40000 USD
V
VTVT
-1.970
(-10.02%)
17.700 USD
V
VXRT
-0.00260
(-0.56%)
0.46340 USD
X
XNCR
-0.12000
(-1.56%)
7.57000 USD
More
News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

8 months ago
Economy News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

1 year ago
Stocks News
More

Title: Cocrystal Pharma

Sector: Healthcare
Industry: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.